Brett N. Tomson

2.0k total citations · 1 hit paper
17 papers, 1.4k citations indexed

About

Brett N. Tomson is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Brett N. Tomson has authored 17 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Brett N. Tomson's work include Cancer Genomics and Diagnostics (5 papers), RNA Research and Splicing (4 papers) and RNA modifications and cancer (3 papers). Brett N. Tomson is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), RNA Research and Splicing (4 papers) and RNA modifications and cancer (3 papers). Brett N. Tomson collaborates with scholars based in United States, Netherlands and Canada. Brett N. Tomson's co-authors include Razelle Kurzrock, Sheryl K. Elkin, Teresa Helsten, Jennifer Carter, Karen M. Arndt, Jennifer Carter, Shumei Kato, Maria Schwaederlé, Timon P.H. Buys and Carole Ober and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Brett N. Tomson

17 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing

2015 589 citations Teresa Helsten, Sheryl K. Elkin et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Brett N. Tomson

Since Specialization

Citations

This map shows the geographic impact of Brett N. Tomson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett N. Tomson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett N. Tomson more than expected).

Fields of papers citing papers by Brett N. Tomson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett N. Tomson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett N. Tomson. The network helps show where Brett N. Tomson may publish in the future.

Co-authorship network of co-authors of Brett N. Tomson

This figure shows the co-authorship network connecting the top 25 collaborators of Brett N. Tomson. A scholar is included among the top collaborators of Brett N. Tomson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett N. Tomson. Brett N. Tomson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research 2020 ·Nature Medicine ·Corrie Painter, Esha Jain, Brett N. Tomson, Michael Dunphy, (unknown), (unknown), (unknown), (unknown), Dewey Kim, Jorge Gómez Tejeda Zañudo, Jason L. Hornick, Yen‐Lin Chen, Priscilla Merriam, Chandrajit P. Raut, George D. Demetri, Brian A. Van Tine, Eric S. Lander, Todd R. Golub, Nikhil Wagle	187
2	Next-generation sequencing of prostate cancer: genomic and pathway alterations, potential actionability patterns, and relative rate of use of clinical-grade testing 2018 ·Cancer Biology & Therapy ·Sadakatsu Ikeda, Sheryl K. Elkin, Brett N. Tomson, Jennifer Carter, Razelle Kurzrock	36
3	Count me in: A patient-driven research initiative to accelerate cancer research. 2018 ·Journal of Clinical Oncology ·Nikhil Wagle, Corrie Painter, Eliezer M. Van Allen, Adam J. Bass, (unknown), Michael Dunphy, (unknown), (unknown), (unknown), (unknown), Brett N. Tomson, (unknown), Esha Jain, Stephanie A. Wankowicz, (unknown), (unknown), (unknown), (unknown), Todd R. Golub, Eric S. Lander	2
4	Genomic Landscape of Malignant Mesotheliomas 2016 ·Molecular Cancer Therapeutics ·Shumei Kato, Brett N. Tomson, Timon P.H. Buys, Sheryl K. Elkin, Jennifer Carter, Razelle Kurzrock	61
5	Cell-Cycle Gene Alterations in 4,864 Tumors Analyzed by Next-Generation Sequencing: Implications for Targeted Therapeutics 2016 ·Molecular Cancer Therapeutics ·Teresa Helsten, Shumei Kato, Maria Schwaederlé, Brett N. Tomson, Timon P.H. Buys, Sheryl K. Elkin, Jennifer Carter, Razelle Kurzrock	34
6	Genomic landscape of malignant mesotheliomas. 2016 ·Journal of Clinical Oncology ·Shumei Kato, Brett N. Tomson, Timon P.H. Buys, Sheryl K. Elkin, Jennifer Carter, Razelle Kurzrock	11
7	Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics 2016 ·Oncotarget ·Philip R. Cohen, Brett N. Tomson, Sheryl K. Elkin, Erica Marchlik, Jennifer Carter, Razelle Kurzrock	32
8	The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing breakdown → 2015 ·Clinical Cancer Research ·Teresa Helsten, Sheryl K. Elkin, (unknown), Brett N. Tomson, Jennifer Carter, Razelle Kurzrock	589
9	Genomic landscape of salivary gland tumors 2015 ·Oncotarget ·Shumei Kato, Sheryl K. Elkin, Maria Schwaederlé, Brett N. Tomson, Teresa Helsten, Jennifer Carter, Razelle Kurzrock	42
10	Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor types 2015 ·Cell Cycle ·Maria Schwaederlé, Sheryl K. Elkin, Brett N. Tomson, (unknown), Razelle Kurzrock	56
11	The many roles of the conserved eukaryotic Paf1 complex in regulating transcription, histone modifications, and disease states 2012 ·Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms ·Brett N. Tomson, Karen M. Arndt	113
12	Effects of the Paf1 Complex and Histone Modifications on snoRNA 3′-End Formation Reveal Broad and Locus-Specific Regulation 2012 ·Molecular and Cellular Biology ·Brett N. Tomson, (unknown), Lawrence E. Heisler, Marinella Gebbia, Corey Nislow, Karen M. Arndt	19
13	Identification of a Role for Histone H2B Ubiquitylation in Noncoding RNA 3′-End Formation Through Mutational Analysis of Rtf1 in Saccharomyces cerevisiae 2011 ·Genetics ·Brett N. Tomson, Christopher P. Davis, Marcie H. Warner, Karen M. Arndt	36
14	APC/C-Cdh1-mediated degradation of the Polo kinase Cdc5 promotes the return of Cdc14 into the nucleolus 2008 ·Genes & Development ·(unknown), Brett N. Tomson, Rami Rahal, Jennifer Paulson, Michael S. Cohen, Jack Taunton, Angelika Amon, Rosella Visintin	68
15	Ribosomal DNA Transcription-Dependent Processes Interfere with Chromosome Segregation 2006 ·Molecular and Cellular Biology ·Brett N. Tomson, Damien D’Amours, (unknown), Luís Aragón, Angelika Amon	34
16	Inheritance of most X‐linked traits is not dominant or recessive, just X‐linked 2004 ·American Journal of Medical Genetics Part A ·William B. Dobyns, (unknown), Brett N. Tomson, April Chan, Allen W. Ho, Nicholas T. Ting, Jan C. Oosterwijk, Carole Ober	120
17	More than blood, a Novel Gene Required for Mammalian Postimplantation Development 2004 ·Molecular and Cellular Biology ·Erica D. Smith, Yanfei Xu, Brett N. Tomson, (unknown), Yuko Fujiwara, Stuart H. Orkin, John D. Crispino	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact